9
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

9
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pyrazinamide APIs Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-13V19226
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pyrazinamide APIs Market Research Report 2025
BUY CHAPTERS

Global Pyrazinamide APIs Market Research Report 2025

Code: QYRE-Auto-13V19226
Report
March 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pyrazinamide APIs Market Size

The global market for Pyrazinamide APIs was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 111 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Pyrazinamide APIs Market

Pyrazinamide APIs Market

Pyrazinamide is an anti-tuberculosis API, and its antibacterial activity is most significant in an acidic environment. The drug needs to be used in combination with other anti-tuberculosis drugs (such as streptomycin, isoniazid, rifampicin, etc.), and exerts a bactericidal effect by interfering with the dehydrogenase of Mycobacterium tuberculosis or converting it into pyrazinoic acid. It is mainly suitable for the treatment of pulmonary tuberculosis, extrapulmonary tuberculosis (such as lymph node tuberculosis, bone tuberculosis) and drug-resistant tuberculosis.
North American market for Pyrazinamide APIs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pyrazinamide APIs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pyrazinamide APIs include Calyx Chemicals and Pharmaceuticals Ltd., Linaria Chemicals (Thailand) Ltd, Minakem, Lupin Limited, Anuh Pharma Ltd., Macleods Pharmaceuticals Ltd., Amsal Chem Private Limited, Taizhou Tianrui Pharmaceutical Co.,Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Chongqing Huapont Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pyrazinamide APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pyrazinamide APIs.
The Pyrazinamide APIs market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pyrazinamide APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pyrazinamide APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pyrazinamide APIs Market Report

Report Metric Details
Report Name Pyrazinamide APIs Market
Accounted market size in year US$ 65.2 million
Forecasted market size in 2031 US$ 111 million
CAGR 8.5%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Min 99%
  • Other
by Application
  • Tablets
  • Capsules
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Calyx Chemicals and Pharmaceuticals Ltd., Linaria Chemicals (Thailand) Ltd, Minakem, Lupin Limited, Anuh Pharma Ltd., Macleods Pharmaceuticals Ltd., Amsal Chem Private Limited, Taizhou Tianrui Pharmaceutical Co.,Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Chongqing Huapont Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pyrazinamide APIs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Pyrazinamide APIs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Pyrazinamide APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Pyrazinamide APIs Market growing?

Ans: The Pyrazinamide APIs Market witnessing a CAGR of 8.5% during the forecast period 2025-2031.

What is the Pyrazinamide APIs Market size in 2031?

Ans: The Pyrazinamide APIs Market size in 2031 will be US$ 111 million.

Who are the main players in the Pyrazinamide APIs Market report?

Ans: The main players in the Pyrazinamide APIs Market are Calyx Chemicals and Pharmaceuticals Ltd., Linaria Chemicals (Thailand) Ltd, Minakem, Lupin Limited, Anuh Pharma Ltd., Macleods Pharmaceuticals Ltd., Amsal Chem Private Limited, Taizhou Tianrui Pharmaceutical Co.,Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Chongqing Huapont Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Pyrazinamide APIs Market report?

Ans: The Applications covered in the Pyrazinamide APIs Market report are Tablets, Capsules

What are the Type segmentation covered in the Pyrazinamide APIs Market report?

Ans: The Types covered in the Pyrazinamide APIs Market report are Min 99%, Other

Recommended Reports

Antibiotic APIs

Oncology APIs

Cardiovascular APIs

1 Pyrazinamide APIs Market Overview
1.1 Product Definition
1.2 Pyrazinamide APIs by Type
1.2.1 Global Pyrazinamide APIs Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Min 99%
1.2.3 Other
1.3 Pyrazinamide APIs by Application
1.3.1 Global Pyrazinamide APIs Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Capsules
1.4 Global Market Growth Prospects
1.4.1 Global Pyrazinamide APIs Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pyrazinamide APIs Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pyrazinamide APIs Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pyrazinamide APIs Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pyrazinamide APIs Production Market Share by Manufacturers (2020-2025)
2.2 Global Pyrazinamide APIs Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pyrazinamide APIs, Industry Ranking, 2023 VS 2024
2.4 Global Pyrazinamide APIs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pyrazinamide APIs Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pyrazinamide APIs, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pyrazinamide APIs, Product Offered and Application
2.8 Global Key Manufacturers of Pyrazinamide APIs, Date of Enter into This Industry
2.9 Pyrazinamide APIs Market Competitive Situation and Trends
2.9.1 Pyrazinamide APIs Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pyrazinamide APIs Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pyrazinamide APIs Production by Region
3.1 Global Pyrazinamide APIs Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pyrazinamide APIs Production Value by Region (2020-2031)
3.2.1 Global Pyrazinamide APIs Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pyrazinamide APIs by Region (2026-2031)
3.3 Global Pyrazinamide APIs Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pyrazinamide APIs Production Volume by Region (2020-2031)
3.4.1 Global Pyrazinamide APIs Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pyrazinamide APIs by Region (2026-2031)
3.5 Global Pyrazinamide APIs Market Price Analysis by Region (2020-2025)
3.6 Global Pyrazinamide APIs Production and Value, Year-over-Year Growth
3.6.1 North America Pyrazinamide APIs Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pyrazinamide APIs Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pyrazinamide APIs Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pyrazinamide APIs Production Value Estimates and Forecasts (2020-2031)
4 Pyrazinamide APIs Consumption by Region
4.1 Global Pyrazinamide APIs Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pyrazinamide APIs Consumption by Region (2020-2031)
4.2.1 Global Pyrazinamide APIs Consumption by Region (2020-2025)
4.2.2 Global Pyrazinamide APIs Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pyrazinamide APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pyrazinamide APIs Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pyrazinamide APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pyrazinamide APIs Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pyrazinamide APIs Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pyrazinamide APIs Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pyrazinamide APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pyrazinamide APIs Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pyrazinamide APIs Production by Type (2020-2031)
5.1.1 Global Pyrazinamide APIs Production by Type (2020-2025)
5.1.2 Global Pyrazinamide APIs Production by Type (2026-2031)
5.1.3 Global Pyrazinamide APIs Production Market Share by Type (2020-2031)
5.2 Global Pyrazinamide APIs Production Value by Type (2020-2031)
5.2.1 Global Pyrazinamide APIs Production Value by Type (2020-2025)
5.2.2 Global Pyrazinamide APIs Production Value by Type (2026-2031)
5.2.3 Global Pyrazinamide APIs Production Value Market Share by Type (2020-2031)
5.3 Global Pyrazinamide APIs Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pyrazinamide APIs Production by Application (2020-2031)
6.1.1 Global Pyrazinamide APIs Production by Application (2020-2025)
6.1.2 Global Pyrazinamide APIs Production by Application (2026-2031)
6.1.3 Global Pyrazinamide APIs Production Market Share by Application (2020-2031)
6.2 Global Pyrazinamide APIs Production Value by Application (2020-2031)
6.2.1 Global Pyrazinamide APIs Production Value by Application (2020-2025)
6.2.2 Global Pyrazinamide APIs Production Value by Application (2026-2031)
6.2.3 Global Pyrazinamide APIs Production Value Market Share by Application (2020-2031)
6.3 Global Pyrazinamide APIs Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Calyx Chemicals and Pharmaceuticals Ltd.
7.1.1 Calyx Chemicals and Pharmaceuticals Ltd. Pyrazinamide APIs Company Information
7.1.2 Calyx Chemicals and Pharmaceuticals Ltd. Pyrazinamide APIs Product Portfolio
7.1.3 Calyx Chemicals and Pharmaceuticals Ltd. Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Calyx Chemicals and Pharmaceuticals Ltd. Main Business and Markets Served
7.1.5 Calyx Chemicals and Pharmaceuticals Ltd. Recent Developments/Updates
7.2 Linaria Chemicals (Thailand) Ltd
7.2.1 Linaria Chemicals (Thailand) Ltd Pyrazinamide APIs Company Information
7.2.2 Linaria Chemicals (Thailand) Ltd Pyrazinamide APIs Product Portfolio
7.2.3 Linaria Chemicals (Thailand) Ltd Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Linaria Chemicals (Thailand) Ltd Main Business and Markets Served
7.2.5 Linaria Chemicals (Thailand) Ltd Recent Developments/Updates
7.3 Minakem
7.3.1 Minakem Pyrazinamide APIs Company Information
7.3.2 Minakem Pyrazinamide APIs Product Portfolio
7.3.3 Minakem Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Minakem Main Business and Markets Served
7.3.5 Minakem Recent Developments/Updates
7.4 Lupin Limited
7.4.1 Lupin Limited Pyrazinamide APIs Company Information
7.4.2 Lupin Limited Pyrazinamide APIs Product Portfolio
7.4.3 Lupin Limited Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Lupin Limited Main Business and Markets Served
7.4.5 Lupin Limited Recent Developments/Updates
7.5 Anuh Pharma Ltd.
7.5.1 Anuh Pharma Ltd. Pyrazinamide APIs Company Information
7.5.2 Anuh Pharma Ltd. Pyrazinamide APIs Product Portfolio
7.5.3 Anuh Pharma Ltd. Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Anuh Pharma Ltd. Main Business and Markets Served
7.5.5 Anuh Pharma Ltd. Recent Developments/Updates
7.6 Macleods Pharmaceuticals Ltd.
7.6.1 Macleods Pharmaceuticals Ltd. Pyrazinamide APIs Company Information
7.6.2 Macleods Pharmaceuticals Ltd. Pyrazinamide APIs Product Portfolio
7.6.3 Macleods Pharmaceuticals Ltd. Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Macleods Pharmaceuticals Ltd. Main Business and Markets Served
7.6.5 Macleods Pharmaceuticals Ltd. Recent Developments/Updates
7.7 Amsal Chem Private Limited
7.7.1 Amsal Chem Private Limited Pyrazinamide APIs Company Information
7.7.2 Amsal Chem Private Limited Pyrazinamide APIs Product Portfolio
7.7.3 Amsal Chem Private Limited Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Amsal Chem Private Limited Main Business and Markets Served
7.7.5 Amsal Chem Private Limited Recent Developments/Updates
7.8 Taizhou Tianrui Pharmaceutical Co.,Ltd.
7.8.1 Taizhou Tianrui Pharmaceutical Co.,Ltd. Pyrazinamide APIs Company Information
7.8.2 Taizhou Tianrui Pharmaceutical Co.,Ltd. Pyrazinamide APIs Product Portfolio
7.8.3 Taizhou Tianrui Pharmaceutical Co.,Ltd. Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Taizhou Tianrui Pharmaceutical Co.,Ltd. Main Business and Markets Served
7.8.5 Taizhou Tianrui Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.9 Zhejiang Haizhou Pharmaceutical Co., Ltd.
7.9.1 Zhejiang Haizhou Pharmaceutical Co., Ltd. Pyrazinamide APIs Company Information
7.9.2 Zhejiang Haizhou Pharmaceutical Co., Ltd. Pyrazinamide APIs Product Portfolio
7.9.3 Zhejiang Haizhou Pharmaceutical Co., Ltd. Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Zhejiang Haizhou Pharmaceutical Co., Ltd. Main Business and Markets Served
7.9.5 Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments/Updates
7.10 Chongqing Huapont Pharmaceutical Co., Ltd.
7.10.1 Chongqing Huapont Pharmaceutical Co., Ltd. Pyrazinamide APIs Company Information
7.10.2 Chongqing Huapont Pharmaceutical Co., Ltd. Pyrazinamide APIs Product Portfolio
7.10.3 Chongqing Huapont Pharmaceutical Co., Ltd. Pyrazinamide APIs Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Chongqing Huapont Pharmaceutical Co., Ltd. Main Business and Markets Served
7.10.5 Chongqing Huapont Pharmaceutical Co., Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pyrazinamide APIs Industry Chain Analysis
8.2 Pyrazinamide APIs Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pyrazinamide APIs Production Mode & Process Analysis
8.4 Pyrazinamide APIs Sales and Marketing
8.4.1 Pyrazinamide APIs Sales Channels
8.4.2 Pyrazinamide APIs Distributors
8.5 Pyrazinamide APIs Customer Analysis
9 Pyrazinamide APIs Market Dynamics
9.1 Pyrazinamide APIs Industry Trends
9.2 Pyrazinamide APIs Market Drivers
9.3 Pyrazinamide APIs Market Challenges
9.4 Pyrazinamide APIs Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Pyrazinamide APIs Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Pyrazinamide APIs Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Pyrazinamide APIs Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Pyrazinamide APIs Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Pyrazinamide APIs Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Pyrazinamide APIs Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Pyrazinamide APIs Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Pyrazinamide APIs, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pyrazinamide APIs as of 2024)
 Table 10. Global Market Pyrazinamide APIs Average Price by Manufacturers (US$/kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Pyrazinamide APIs, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Pyrazinamide APIs, Product Offered and Application
 Table 13. Global Key Manufacturers of Pyrazinamide APIs, Date of Enter into This Industry
 Table 14. Global Pyrazinamide APIs Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pyrazinamide APIs Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Pyrazinamide APIs Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Pyrazinamide APIs Production Value Market Share by Region (2020-2025)
 Table 19. Global Pyrazinamide APIs Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Pyrazinamide APIs Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Pyrazinamide APIs Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Pyrazinamide APIs Production (Tons) by Region (2020-2025)
 Table 23. Global Pyrazinamide APIs Production Market Share by Region (2020-2025)
 Table 24. Global Pyrazinamide APIs Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Pyrazinamide APIs Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Pyrazinamide APIs Market Average Price (US$/kg) by Region (2020-2025)
 Table 27. Global Pyrazinamide APIs Market Average Price (US$/kg) by Region (2026-2031)
 Table 28. Global Pyrazinamide APIs Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Pyrazinamide APIs Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Pyrazinamide APIs Consumption Market Share by Region (2020-2025)
 Table 31. Global Pyrazinamide APIs Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Pyrazinamide APIs Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Pyrazinamide APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Pyrazinamide APIs Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Pyrazinamide APIs Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Pyrazinamide APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Pyrazinamide APIs Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Pyrazinamide APIs Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Pyrazinamide APIs Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Pyrazinamide APIs Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Pyrazinamide APIs Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Pyrazinamide APIs Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Pyrazinamide APIs Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Pyrazinamide APIs Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Pyrazinamide APIs Production (Tons) by Type (2020-2025)
 Table 46. Global Pyrazinamide APIs Production (Tons) by Type (2026-2031)
 Table 47. Global Pyrazinamide APIs Production Market Share by Type (2020-2025)
 Table 48. Global Pyrazinamide APIs Production Market Share by Type (2026-2031)
 Table 49. Global Pyrazinamide APIs Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Pyrazinamide APIs Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Pyrazinamide APIs Production Value Market Share by Type (2020-2025)
 Table 52. Global Pyrazinamide APIs Production Value Market Share by Type (2026-2031)
 Table 53. Global Pyrazinamide APIs Price (US$/kg) by Type (2020-2025)
 Table 54. Global Pyrazinamide APIs Price (US$/kg) by Type (2026-2031)
 Table 55. Global Pyrazinamide APIs Production (Tons) by Application (2020-2025)
 Table 56. Global Pyrazinamide APIs Production (Tons) by Application (2026-2031)
 Table 57. Global Pyrazinamide APIs Production Market Share by Application (2020-2025)
 Table 58. Global Pyrazinamide APIs Production Market Share by Application (2026-2031)
 Table 59. Global Pyrazinamide APIs Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Pyrazinamide APIs Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Pyrazinamide APIs Production Value Market Share by Application (2020-2025)
 Table 62. Global Pyrazinamide APIs Production Value Market Share by Application (2026-2031)
 Table 63. Global Pyrazinamide APIs Price (US$/kg) by Application (2020-2025)
 Table 64. Global Pyrazinamide APIs Price (US$/kg) by Application (2026-2031)
 Table 65. Calyx Chemicals and Pharmaceuticals Ltd. Pyrazinamide APIs Company Information
 Table 66. Calyx Chemicals and Pharmaceuticals Ltd. Pyrazinamide APIs Specification and Application
 Table 67. Calyx Chemicals and Pharmaceuticals Ltd. Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 68. Calyx Chemicals and Pharmaceuticals Ltd. Main Business and Markets Served
 Table 69. Calyx Chemicals and Pharmaceuticals Ltd. Recent Developments/Updates
 Table 70. Linaria Chemicals (Thailand) Ltd Pyrazinamide APIs Company Information
 Table 71. Linaria Chemicals (Thailand) Ltd Pyrazinamide APIs Specification and Application
 Table 72. Linaria Chemicals (Thailand) Ltd Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 73. Linaria Chemicals (Thailand) Ltd Main Business and Markets Served
 Table 74. Linaria Chemicals (Thailand) Ltd Recent Developments/Updates
 Table 75. Minakem Pyrazinamide APIs Company Information
 Table 76. Minakem Pyrazinamide APIs Specification and Application
 Table 77. Minakem Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 78. Minakem Main Business and Markets Served
 Table 79. Minakem Recent Developments/Updates
 Table 80. Lupin Limited Pyrazinamide APIs Company Information
 Table 81. Lupin Limited Pyrazinamide APIs Specification and Application
 Table 82. Lupin Limited Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 83. Lupin Limited Main Business and Markets Served
 Table 84. Lupin Limited Recent Developments/Updates
 Table 85. Anuh Pharma Ltd. Pyrazinamide APIs Company Information
 Table 86. Anuh Pharma Ltd. Pyrazinamide APIs Specification and Application
 Table 87. Anuh Pharma Ltd. Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. Anuh Pharma Ltd. Main Business and Markets Served
 Table 89. Anuh Pharma Ltd. Recent Developments/Updates
 Table 90. Macleods Pharmaceuticals Ltd. Pyrazinamide APIs Company Information
 Table 91. Macleods Pharmaceuticals Ltd. Pyrazinamide APIs Specification and Application
 Table 92. Macleods Pharmaceuticals Ltd. Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Macleods Pharmaceuticals Ltd. Main Business and Markets Served
 Table 94. Macleods Pharmaceuticals Ltd. Recent Developments/Updates
 Table 95. Amsal Chem Private Limited Pyrazinamide APIs Company Information
 Table 96. Amsal Chem Private Limited Pyrazinamide APIs Specification and Application
 Table 97. Amsal Chem Private Limited Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 98. Amsal Chem Private Limited Main Business and Markets Served
 Table 99. Amsal Chem Private Limited Recent Developments/Updates
 Table 100. Taizhou Tianrui Pharmaceutical Co.,Ltd. Pyrazinamide APIs Company Information
 Table 101. Taizhou Tianrui Pharmaceutical Co.,Ltd. Pyrazinamide APIs Specification and Application
 Table 102. Taizhou Tianrui Pharmaceutical Co.,Ltd. Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 103. Taizhou Tianrui Pharmaceutical Co.,Ltd. Main Business and Markets Served
 Table 104. Taizhou Tianrui Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 105. Zhejiang Haizhou Pharmaceutical Co., Ltd. Pyrazinamide APIs Company Information
 Table 106. Zhejiang Haizhou Pharmaceutical Co., Ltd. Pyrazinamide APIs Specification and Application
 Table 107. Zhejiang Haizhou Pharmaceutical Co., Ltd. Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 108. Zhejiang Haizhou Pharmaceutical Co., Ltd. Main Business and Markets Served
 Table 109. Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Chongqing Huapont Pharmaceutical Co., Ltd. Pyrazinamide APIs Company Information
 Table 111. Chongqing Huapont Pharmaceutical Co., Ltd. Pyrazinamide APIs Specification and Application
 Table 112. Chongqing Huapont Pharmaceutical Co., Ltd. Pyrazinamide APIs Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 113. Chongqing Huapont Pharmaceutical Co., Ltd. Main Business and Markets Served
 Table 114. Chongqing Huapont Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Pyrazinamide APIs Distributors List
 Table 118. Pyrazinamide APIs Customers List
 Table 119. Pyrazinamide APIs Market Trends
 Table 120. Pyrazinamide APIs Market Drivers
 Table 121. Pyrazinamide APIs Market Challenges
 Table 122. Pyrazinamide APIs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pyrazinamide APIs
 Figure 2. Global Pyrazinamide APIs Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Pyrazinamide APIs Market Share by Type: 2024 VS 2031
 Figure 4. Min 99% Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Pyrazinamide APIs Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Pyrazinamide APIs Market Share by Application: 2024 VS 2031
 Figure 8. Tablets
 Figure 9. Capsules
 Figure 10. Global Pyrazinamide APIs Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pyrazinamide APIs Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Pyrazinamide APIs Production Capacity (Tons) & (2020-2031)
 Figure 13. Global Pyrazinamide APIs Production (Tons) & (2020-2031)
 Figure 14. Global Pyrazinamide APIs Average Price (US$/kg) & (2020-2031)
 Figure 15. Pyrazinamide APIs Report Years Considered
 Figure 16. Pyrazinamide APIs Production Share by Manufacturers in 2024
 Figure 17. Global Pyrazinamide APIs Production Value Share by Manufacturers (2024)
 Figure 18. Pyrazinamide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Pyrazinamide APIs Revenue in 2024
 Figure 20. Global Pyrazinamide APIs Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Pyrazinamide APIs Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Pyrazinamide APIs Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 23. Global Pyrazinamide APIs Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Pyrazinamide APIs Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. Europe Pyrazinamide APIs Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Pyrazinamide APIs Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Pyrazinamide APIs Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Pyrazinamide APIs Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 29. Global Pyrazinamide APIs Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 31. North America Pyrazinamide APIs Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. Canada Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 34. Europe Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Europe Pyrazinamide APIs Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. France Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. U.K. Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Italy Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Russia Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Asia Pacific Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Asia Pacific Pyrazinamide APIs Consumption Market Share by Region (2020-2031)
 Figure 43. China Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Japan Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. South Korea Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. China Taiwan Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Southeast Asia Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. India Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Latin America, Middle East & Africa Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Latin America, Middle East & Africa Pyrazinamide APIs Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Brazil Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Turkey Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. GCC Countries Pyrazinamide APIs Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Global Production Market Share of Pyrazinamide APIs by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Pyrazinamide APIs by Type (2020-2031)
 Figure 57. Global Pyrazinamide APIs Price (US$/kg) by Type (2020-2031)
 Figure 58. Global Production Market Share of Pyrazinamide APIs by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Pyrazinamide APIs by Application (2020-2031)
 Figure 60. Global Pyrazinamide APIs Price (US$/kg) by Application (2020-2031)
 Figure 61. Pyrazinamide APIs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension